Supernus Pharmaceuticals Inc (SUPN)

Überblick Nachrichten Preisverlauf Optionskette Financials Warum fällt SUPN? Forum Prognose

Finanzdaten der Supernus Pharmaceuticals Inc-Aktie (SUPN)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	10.43% 165.45	149.82	174.16	175.69	168.32
Cost Of Revenue	6.75% 16.83	15.76	26.10	17.58	17.92
Gross Profit	10.86% 148.63	134.06	148.06	158.11	150.41
Operating Expenses	5.43% 136.49	144.32	126.66	117.26	127.84
Benefits Costs and Expenses	4.41% 148.78	155.66	147.78	130.75	142.02
Costs And Expenses	4.23% 153.31	160.08	152.75	134.84	145.76
Depreciation and Amortization	16.67% 0.50	0.60	0.60	0.60	0.60
Operating Income/Loss	218.38% 12.14	-10.26	21.41	40.84	22.57
Nonoperating Income/Loss	2.33% 4.528	4.425	4.977	4.098	3.733
Income/Loss From Continuing Operations Before Tax	385.87% 16.67	-5.831	26.38	44.94	26.30
Income Tax Expense/Benefit, Deferred	79.50% -7.162	-3.99	-0.072	-6.467	-8.115
Income Tax Expense/Benefit	197.23% -5.83	5.996	11.05	6.446	6.386
Income/Loss From Continuing Operations After Tax	290.23% 22.50	-11.83	15.33	38.50	19.92
Net Income/Loss	290.23% 22.50	-11.83	15.33	38.50	19.92
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	0.29% 56.02	55.86	0.1229	55.15	54.98
Diluted Average Shares	1.39% 56.64	55.86	0.1674	56.02	55.72
Basic Earnings Per Share	290.48% 0.40	-0.21	0.28	0.70	0.36
Diluted Earnings Per Share	290.48% 0.40	-0.21	0.27	0.69	0.36
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-

ALKS

$28.92

3.60%

ELAN

$17.47

0.69%

RDY

$14.15

0.28%

VTRS

$10.33

2.09%

NBIX

$140.40

3.15%

UTHR

$380.47

2.80%